Home › Entities › sulfonamide › sulfadiazine

sulfadiazine

chemical compound
Class type of: sulfonamide, pyrimidine Q2555060

Facts

14 properties
Instance of
type of chemical entity
Subclass of
sulfonamide, pyrimidine[4][5]
Has use
medication[6]
Canonical SMILES
C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N[2]
Chemical formula
C₁₀H₁₀N₄O₂S[3]
Defined daily dose
0.6
Has active ingredient
Sulfadiazine
Mass
250.052447
Medical condition treated
nocardiosis, toxoplasmosis, urinary tract infection, malaria, gram-negative bacterial infection, malaria (1994–present)
Melting point
255.0
Stylized name
sulfADIAZINE
Subject has role
anti-infective agent, antiprotozoal, Coccidiostat, essential medicine, bactericide
WHO Aware Classification
access
World Health Organisation international non-proprietary name
sulfadiazine
🏷️ Also known as
en sulfadiazine en Sulfadiazine en Sulfadiazinum en Sulfapyrimidine en Sulfolex en Sulphadiazine en 2-sulfanilamidopyrimidine en 2-sulfanilylaminopyrimidine en 4-amino-N-2-pyrimidinylbenzenesulfonamide en Adiazine en Coco-diazine en Diazyl en N1-2-pyrimidinylsulfanilamide en N(1)-2-Pyrimidinylsulfanilamide en N1-2-pyrimidylsulfanilamide en N(1)-2-Pyrimidylsulfanilamide en sulfadiazin en Sulfadiazina ar Sulfadiazine ar Sulfapyrimidine
🔖 Identifiers · 47
OpenAlex ID
C2778269047
ATC code
J01EC02
CAS Registry Number
68-35-9
ChEBI ID
9328
ChEMBL ID
CHEMBL439
ChemSpider ID
5026
DSSTOX compound identifier
DTXCID5024130
DSSTox substance ID
DTXSID7044130
DeCS ID
13796
DrugBank ID
DB00359
DrugCentral ID
2500
EC number
200-685-8
Show all 47 identifiers +35
ECHA Substance Infocard ID
100.000.623
Electronic Essential Medicines List medicine ID
385
Freebase ID
/m/0c77d0
Gmelin number
219136
Gran Enciclopèdia Catalana ID
sulfadiazina
Gran Enciclopèdia Catalana ID (former scheme)
0144277
Human Metabolome Database ID
HMDB0014503
IEDB Epitope ID
140083
InChI
InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)
InChIKey
SEEPANYCNGTZFQ-UHFFFAOYSA-N
Interlingual Index ID
i59765
KEGG ID
C07658, D00587
MassBank accession ID
MSBNK-Athens_Univ-AU101101, MSBNK-Athens_Univ-AU101102, MSBNK-Athens_Univ-AU101103, MSBNK-Athens_Univ-AU101104, MSBNK-Eawag-EA017901, MSBNK-Eawag-EA017902, MSBNK-Eawag-EA017903, MSBNK-Eawag-EA017904, MSBNK-Eawag-EA017905, MSBNK-Eawag-EA017906, MSBNK-Eawag-EA017907, MSBNK-Eawag-EA017908, MSBNK-Eawag-EA017909, MSBNK-Eawag-EA017910, MSBNK-Eawag-EA017911, MSBNK-Eawag-EA017912, MSBNK-Eawag-EA017913, MSBNK-Eawag-EA017914
MeSH concept ID
M0020740
MeSH descriptor ID
D013411
MeSH tree code
D02.065.884.060.170, D02.065.884.725.755, D02.092.146.807.755, D02.455.426.559.389.085.170, D02.886.590.700.090.170, D02.886.590.700.725.755
MedlinePlus drug identifier
a682130
Microsoft Academic ID (discontinued)
2778269047, 2909589382
NALT ID
10517
NDF-RT ID
N0000145882
NSC number
35600, 757324
National Drug Code
62705-0230, 62135-842, 86129-0001, 42806-757, 62705-0229, 72672-003, 71236-0003, 38779-3224
Probes And Drugs ID
PD001750
PubChem CID
5215
Quora topic ID
Sulfadiazine
RTECS number
WP1925000
Reaxys registry number
235192
RxNorm CUI
10171
SPLASH
splash10-0a4i-0910000000-bd163c77861c5a8afa49, splash10-0a4i-0900000000-260a572b5c7f3c070c26, splash10-052r-0900000000-580f983ba25c4cb3eb30, splash10-0a4i-1900000000-8dc8c152ec6044f1c2e9, splash10-0udi-0090000000-23afa7ea3ef67a93a2e6, splash10-0pb9-3960000000-355dcad6c59ae9c75fb7, splash10-0a4i-4900000000-337c5e4fc08cc648b85d, splash10-0a4l-8900000000-63cd0dba3c4894d64ae1, splash10-0a4l-9500000000-64c8a8332030e3f700a1, splash10-05mo-9300000000-746250effd08ec8bf51b, splash10-0udi-0090000000-e8005ac37727f1c540d8, splash10-0pb9-2960000000-ff127258fb7c09ae3665, splash10-0a4i-4900000000-4fa5b350b17254bc9a1a, splash10-0a4l-8900000000-4a998ad7772889643c1f, splash10-0a4l-9500000000-7e0d8190b4e7f7ced956, splash10-05mo-9300000000-9cca42d677a6ef782a2c, splash10-0a4i-1900000000-4b5c2f7e29a6399f475c
SureChEMBL ID
24176
UMLS CUI
C0038675
UNII
0N7609K889
UniChem compound ID
174459
WikiProjectMed ID
Sulfadiazine
WordNet 3.1 Synset ID
04359014-n

Report an error or request removal Lineage (PROV-JSON)

🔗 Connections
Medical condition treated 5
malaria, malaria, urinary tract infection, toxoplasmosis, nocardiosis
← Drug or therapy used for treatment 5
malaria, urinary tract infection, toxoplasmosis, nocardiosis, granulomatous amebic encephalitis
Subject has role 3
bactericide, essential medicine, antiprotozoal
Belongs to 1
World Health Organization Model List of Essential Medicines
Has use 1
medication
Subclass of 1
sulfonamide
← Has cause 1
hyperammonemia
Press Enter · cited answer in seconds

Summary

sulfadiazine is a type of chemical entity[1].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . PubChem. Retrieved . wikidata.org.
  2. [3] ↑ . PubChem. Retrieved . wikidata.org.
  3. [4] ↑ . NDF-RT. Retrieved . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . DrugBank. wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). sulfadiazine. Retrieved November 6, 2026, from https://4ort.xyz/entity/sulfadiazine
MLA “sulfadiazine.” 4ort.xyz Knowledge Graph, 4ort.xyz, 6 Nov. 2026, https://4ort.xyz/entity/sulfadiazine.
BibTeX @misc{4ortxyz_sulfadiazine_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{sulfadiazine}}, year = {2026}, url = {https://4ort.xyz/entity/sulfadiazine}, note = {Accessed: 2026-11-06}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): sulfadiazine — https://4ort.xyz/entity/sulfadiazine (retrieved 2026-11-06)

Canonical URL: https://4ort.xyz/entity/sulfadiazine · Last refreshed: